跳至主要内容
临床试验/NCT00675675
NCT00675675已完成不适用

TRECC: Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders

John Piacentini2 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2007年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
53
试验地点
2
主要终点
Clinical Global Impressions - Improvement

研究概览

简要总结

The study aims to clarify the functional anatomy of key brain circuits associated with cognitive control in children and adolescents with chronic tic disorders (CTD) and to compare and contrast hypothesized mechanisms related to increased tic control associated with Habit Reversal Training, a behavioral treatment that been previously shown to be effective in treating CTD. We also seek to better understand the relationship between fMRI and quantitative EEG in relevant brain circuits with the hope of establishing EEG as a valid and cost-effective marker of treatment responsiveness. A total of 25 subjects will be randomized to 10 weeks of Habit Reversal Training (HRT), a behavioral treatment, and 25 to 10 weeks of minimal-contact waitlist. Treatment responders will be re-assessed at three months. Waitlist nonresponders will be provided with 10 weeks of HRT. Study assessments, including a neurocognitive battery and quantitative EEG will be administered at baseline, Wk 5, Wk 10, and 3-month follow-up. Neuroimaging (fMRI) will be conducted at baseline and Wk 10.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
9 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • DSM-IV diagnostic criteria for CTD (CMVT or TS)
  • Clinical Global Impressions - Severity Score > 3 (moderately ill or worse)
  • YGTSS Total Score > 14 (or Total Score > 10 if CTD with motor tics only)
  • Unmedicated or on stable psychotropic medication for at least 6 weeks prior to study entry, with no planned changes for duration of study participation
  • Child is fluent English speaker
  • Parental Informed Consent and Child Informed Assent.

排除标准

  • Total YGTSS Score>35 (Cases above this threshold otherwise eligible will be reviewed by Clinical Caseness Panel for potential study participation)
  • IQ < 80 on the Wechsler Abbreviated Scale of Intelligence (WASI)
  • Problematic Substance Use or DSM-IV Conduct Disorder in past 3 months
  • Lifetime DSM-IV diagnosis of PDD, Mania, or Psychotic Disorder
  • Any serious psychiatric, psychosocial, or neurological condition requiring immediate treatment other than that provided in the current study
  • Previous treatment with four or more sessions of HRT for tics
  • Contraindication to fMRI scan

结局指标

主要结局

Clinical Global Impressions - Improvement

时间窗: Wks 0, 5, 10

次要结局

  • Yale Global Tic Severity Scale(Wks 0, 5, 10)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

John Piacentini

Professor in Residence

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验